Загрузка...
Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?
Variable prevalence of subclinical Cushing's syndrome (SCS) has been reported in patients with type 2 diabetes mellitus (T2DM), making the need for screening in this population uncertain. It is unknown if this variability is solely due to study-related methodological differences or a reflection...
Сохранить в:
| Опубликовано в: : | Endocr Connect |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bioscientifica Ltd
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621608/ https://ncbi.nlm.nih.gov/pubmed/26420669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-15-0078 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|